The DOI matches its Crossref record; 88 of the 90 references it cites were found in a registry or an index.
Changes of Sleep Architecture, Spectral Composition of Sleep EEG, the Nocturnal Secretion of Cortisol, ACTH, GH, Prolactin, Melatonin, Ghrelin, and Leptin, and the DEX-CRH Test in Depressed Patients during Treatment with Mirtazapine
Abstract
The noradrenergic and specific serotoninergic antidepressant mirtazapine improves sleep, modulates hormone secretion including blunting of hypothalamic-pituitary-adrenocortical (HPA) activity, and may prompt increased appetite and weight gain. The simultaneous investigation of sleep electroencephalogram (EEG) and hormone secretion during antidepressive treatment helps to further elucidate these effects. We examined sleep EEG (for later conventional and quantitative analyses) and the nocturnal concentrations of cortisol, adrenocorticotropin (ACTH), growth hormone (GH), prolactin, melatonin and the key factors of energy balance, ghrelin, and leptin before and after 28 days of treatment of depressed patients (seven women, three men, mean age 39.9+/-4.2 years) with mirtazapine. In addition, a sleep EEG was recorded at day 2 and the dexamethasone-corticotropin-releasing hormone (DEX-CRH) test was performed to assess HPA activity at days -3 and 26. Psychometry and mirtazapine plasma concentrations were measured weekly. Already at day 2, sleep continuity was improved. This effect persisted at day 28, when slow-wave sleep, low-delta, theta and alpha activity, leptin and (0300-0700) melatonin increased, and cortisol and ghrelin decreased. ACTH and prolactin remained unchanged. The first two specimens of GH collected after the start of quantitative EEG analysis were reduced at day 28. The DEX-CRH test showed, at day 26, a blunting of the overshoot of ACTH and cortisol found at day -3.…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some patients show improvement of sleep quality already after the first drug dose [15]”
From Effects of Antidepressants on Sleep (2017) · cites this paper as [15]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 11,772
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Hobson, J. A. (1969) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(69)90021-2 · Cited by 5,215
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
Ghrelin induces adiposity in rodents
Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Flagged first, then by citations
2 of the 90 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Spitzer RL, Williams JB, Gibbon M (1987). The structured clinical interview for DSM-III-R: SCID. German version: Wittchen HU, Zaudig M, Schramm E, Spengler P, Mombour W. SKID—Strukturiertes Klinisches Inverview für DSM-III-R. Beltz: Weinheim.
Cited by
Sorted by citations
Goshen, I., Kreisel, T., Ben-Menachem-Zidon, O., Licht, T., Weidenfeld, J., Ben-Hur, T., & Yirmiya, R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002055 · Cited by 762
Effects of Antidepressants on Sleep
Wichniak, A., Wierzbicka, A., Walęcka, M., & Jernajczyk, W. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0816-4 · Cited by 557
Self-citationComorbidity of insomnia and depression
Staner, L. (2010) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2009.09.003 · Cited by 481
Interleukin-1 (IL-1): A central regulator of stress responses
Goshen, I., & Yirmiya, R. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.10.001 · Cited by 399
ISRUC-Sleep: A comprehensive public dataset for sleep researchers
Khalighi, S., Sousa, T., dos Santos, J. M., & Nunes, U. (2015) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2015.10.013 · Cited by 393
Steiger, A., & Pawlowski, M. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030607 · Cited by 333
Self-citationWake and sleep EEG provide biomarkers in depression
Steiger, A., & Kimura, M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.013 · Cited by 310
Self-citationREM Sleep Instability – A New Pathway for Insomnia?
Riemann, D. W., Spiegelhalder, K., Nissen, C., Hirscher, V., Baglioni, C., & Feige, B. (2012) · Pharmacopsychiatry · doi:10.1055/s-0031-1299721 · Cited by 254
Neuroendocrinological mechanisms of actions of antidepressant drugs
Schüle, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01516.x · Cited by 167
The Neurobiological Mechanisms and Treatments of REM Sleep Disturbances in Depression
Wang, Y., Li, R., Zhang, M., Zhang, Z., Qu, W., & Huang, Z. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150310002540 · Cited by 167
Sleep and Antidepressant Treatment
Wichniak, A., Wierzbicka, A., & Jernajczyk, W. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803523608 · Cited by 142
Self-citationAntagonism of serotonergic 5‐HT2A/2Creceptors: mutual improvement of sleep, cognition and mood?
Landolt, H., & Wehrle, R. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06718.x · Cited by 136
Assessment and treatment of insomnia in adult patients with alcohol use disorders
Brower, K. J. (2015) · Alcohol · doi:10.1016/j.alcohol.2014.12.003 · Cited by 134
Sleep Loss as a Factor to Induce Cellular and Molecular Inflammatory Variations
Hurtado‐Alvarado, G., Pavón, L., Castillo-García, S. A., Hernández, M. E., Domı́nguez-Salazar, E., Velázquez‐Moctezuma, J., & Gómez‐González, B. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/801341 · Cited by 130
Hutka, P., Krivosova, M., Muchova, Z., Tonhajzerová, I., Hamrakova, A., Mlyncekova, Z., Mokrý, J., & Ondrejka, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031333 · Cited by 129
Sleep as a biomarker for depression
Wichniak, A., Wierzbicka, A., & Jernajczyk, W. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.812067 · Cited by 123
Self-citationThe effect of insomnia on development of Alzheimer’s disease
Sadeghmousavi, S., Eskian, M., Rahmani, F., & Rezaei, N. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01960-9 · Cited by 122
The TNF-α System: Functional Aspects in Depression, Narcolepsy and Psychopharmacology
Berthold-Losleben, M., & Himmerich, H. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777238 · Cited by 119
Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
Ghrelin in psychiatric disorders – A review
Wittekind, D. A., & Kluge, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.11.013 · Cited by 110
Hansson, C., Haage, D., Taube, M., Egecioglu, E., Salomé, N., & Dickson, S. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.002 · Cited by 105
Role of sleep in the regulation of the immune system and the pituitary hormones
Gómez‐González, B., Domı́nguez-Salazar, E., Hurtado‐Alvarado, G., Esqueda-León, E., Santana-Miranda, R., Rojas-Zamorano, J. A., & Velázquez‐Moctezuma, J. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06616.x · Cited by 104
The impact of treatment on HPA axis activity in unipolar major depression
McKay, M. S., & Zakzanis, K. K. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.07.012 · Cited by 103
Kluge, M., SCHÜSSLER, P., Dresler, M., Schmidt, D., Yassouridis, A., Uhr, M., & Steiger, A. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.09.002 · Cited by 93
Self-citationSong, J. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0330-8 · Cited by 84
Assessment of Sleep in Ventilator-Supported Critically Ill Patients
Ambrogio, C., Koebnick, J., Quan, S. F., Ranieri, V. M., & Parthasarathy, S. (2008) · SLEEP · doi:10.1093/sleep/31.11.1559 · Cited by 81
The protective effects of Ghrelin/GHSR on hippocampal neurogenesis in CUMS mice
Huang, H., Chen, X., Han, Q.-Q., Wang, J., Pilot, A., Yu, R., Liu, Q., Li, B., Wu, G.-C., Wang, Y., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.013 · Cited by 79
Serum Ghrelin and Leptin Levels in Patients with Depression and the Effects of Treatment
Özsoy, S., Beşirli, A., Abdülrezzak, Ü., & Baştürk, M. (2014) · Psychiatry Investigation · doi:10.4306/pi.2014.11.2.167 · Cited by 79
Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse
Haney, M., Hart, C. L., Vosburg, S. K., Comer, S. D., Collins, S. L., Cooper, Z. D., & Foltin, R. W. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1888-6 · Cited by 79
Karsten, J., Hagenauw, L. A., Kamphuis, J., & Lancel, M. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881116681399 · Cited by 79
Linking Stress and Infertility: A Novel Role for Ghrelin
Sominsky, L., Hodgson, D. M., McLaughlin, E. A., Smith, R., Wall, H. M., & Spencer, S. J. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1133 · Cited by 79
The role of the circadian system in the etiology of depression
de Leeuw, M., Verhoeve, S. I., van der Wee, N. J. A., van Hemert, A. M., Vreugdenhil, E., & Coomans, C. P. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105383 · Cited by 81
Ghrelin in mental health, sleep, memory
Steiger, A., Dresler, M., SCHÜSSLER, P., & Kluge, M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.02.013 · Cited by 73
Self-citationKluge, M., SCHÜSSLER, P., & Steiger, A. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.01.006 · Cited by 72
Self-citationMarcinkowska, M., Śniecikowska, J., Fajkis-Zajączkowska, N., Paśko, P., Franczyk, W., & Kołaczkowski, M. (2020) · CNS Drugs · doi:10.1007/s40263-020-00707-7 · Cited by 65
Ghrelin Plasma Levels Are Not Altered in Major Depression
Kluge, M., SCHÜSSLER, P., Schmid, D. A., Uhr, M., Kleyer, S., Yassouridis, A., & Steiger, A. (2009) · Neuropsychobiology · doi:10.1159/000223731 · Cited by 64
Self-citationNeuroscience-driven discovery and development of sleep therapeutics
Dresler, M., Spoormaker, V. I., Beitinger, P., Czisch, M., Kimura, M., Steiger, A., & Holsboer, F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.012 · Cited by 63
Self-citationSchüle, C., Baghai, T. C., Eser, D., Zwanzger, P., Jordan, M., Buechs, R., & Rupprecht, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0382-7 · Cited by 63
Impaired off-line memory consolidation in depression
Dresler, M., Kluge, M., Genzel, L., SCHÜSSLER, P., & Steiger, A. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.002 · Cited by 62
Self-citationGhrelin as a Stress Hormone: Implications for Psychiatric Illness
Stone, L. A., Harmatz, E. S., & Goosens, K. A. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.05.013 · Cited by 62
Effects of exercise timing on sleep architecture and nocturnal blood pressure in prehypertensives
Collier, S. R., Fairbrother, K. R., Cartner, B. W., Alley, J., Curry, C. D., Dickinson, D., & Morris, D. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s73688 · Cited by 56
Roux, F., & Kryger, M. H. (2010) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2010.02.008 · Cited by 54
Treatment of prehypertension: lifestyle and/or medication
Collier, S. R., & Landram, M. J. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s29138 · Cited by 54
Ancoli‐Israel, S., Vanover, K. E., Weiner, D. M., Davis, R. E., & van Kammen, D. P. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.10.004 · Cited by 54
Carlini, V. P., Machado, D. G., Buteler, F., Ghersi, M., Ponzio, M. F., Martini, A. C., Schiöth, H. B., de Cúneo, M. F., Rodrigues, A. L. S., & de Barioglio, S. R. (2012) · Peptides · doi:10.1016/j.peptides.2012.03.031 · Cited by 53
Ghrelin as a Neuroprotective and Palliative Agent in Alzheimer's and Parkinson's Disease
dos Santos, V. V., Rodrigues, A. L. S., de Lima, T. C. M., de Barioglio, S. R., Raisman‐Vozari, R., & Prediger, R. D. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990411 · Cited by 53
Mood disorders: A potential link between ghrelin and leptin on human body?
Zarouna, S. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i2.103 · Cited by 53
Algül, Ş., & Özçelik, O. (2018) · Psychiatry Investigation · doi:10.30773/pi.2017.05.24 · Cited by 53
Neuroimmune endocrine effects of antidepressants
Carvalho, L. A. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s16409 · Cited by 52
Prescription Drugs Used in Insomnia
Dujardin, S., Pijpers, A., & Pevernagie, D. (2020) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2020.02.002 · Cited by 52
Biological consequences of disturbed sleep: Important mediators of health?1
Okun, M. L. (2011) · Japanese Psychological Research · doi:10.1111/j.1468-5884.2011.00463.x · Cited by 50
Silva, S., Bicker, J., Falcão, A. C., & Fortuna, A. C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111975 · Cited by 49
Mirtazapine Provokes Periodic Leg Movements during Sleep in Young Healthy Men
Fulda, S., Kloiber, S. M., Dose, T., Lucae, S., Holsboer, F., Schaaf, L., & Hennings, J. M. (2013) · SLEEP · doi:10.5665/sleep.2622 · Cited by 48
Zambelli, Z., Halstead, E. J., Fidalgo, A. R., & Dimitriou, D. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.668930 · Cited by 46
Ishitobi, Y., Kohno, K., Kanehisa, M., Inoue, A., Imanaga, J., Maruyama, Y., Ninomiya, T., Higuma, H., Okamoto, S., Tanaka, Y., et al. (2012) · Neuropsychobiology · doi:10.1159/000339948 · Cited by 45
α-Adrenergic Receptor Function, Arousal and Sleep: Mechanisms and Therapeutic Implications
Broese, M., Riemann, D. W., Hein, L., & Nissen, C. (2012) · Pharmacopsychiatry · doi:10.1055/s-0031-1299728 · Cited by 44
Antidepressants in Alzheimer’s Disease: A Focus on the Role of Mirtazapine
Correia, A. S., & Vale, N. (2021) · Pharmaceuticals · doi:10.3390/ph14090930 · Cited by 42
The Effects of Mirtazapine on Sleep in Patients with Major Depressive Disorder
Dolder, C. R., Nelson, M. H., & Iler, C. A. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400305 · Cited by 42
Çakır, S. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3201 · Cited by 41
Prescription Drugs Used in Insomnia
Dujardin, S., Pijpers, A., & Pevernagie, D. (2018) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2018.03.001 · Cited by 40
Hypersomnia in Mood Disorders: a Rapidly Changing Landscape
Plante, D. T. (2015) · Current Sleep Medicine Reports · doi:10.1007/s40675-015-0017-9 · Cited by 38
Sleep and psychiatric disorders: Bidirectional interactions and shared neurobiological mechanisms
Hyndych, A., Koval, K., Dzeruzhynska, N., & Mader, E. C. (2025) · PLOS mental health. · doi:10.1371/journal.pmen.0000531 · Cited by 36
Neural correlates of plasma acylated ghrelin level in individuals with major depressive disorder
Matsuo, K., Nakano, M., Nakashima, M., Watanuki, T., Egashira, K., Matsubara, T., & Watanabe, Y. (2012) · Brain Research · doi:10.1016/j.brainres.2012.07.027 · Cited by 35
Ramaekers, J. G., Conen, S., de Kam, P. J., Braat, S., Peeters, P. A. M., Theunissen, E. L., & Ivgy-May, N. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2149-4 · Cited by 35
Clinical Pharmacology of Other Drugs Used as Hypnotics
Buysse, D. J., & Tyagi, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24288-2.00042-8 · Cited by 34
Pawlowski, M. A., Gazea, M., Wollweber, B., Dresler, M., Holsboer, F., Keck, M. E., Steiger, A., Adamczyk, M., & Mikoteit, T. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.03.026 · Cited by 34
Self-citationThe Development of the Rotigotine Transdermal Patch
Waters, C. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.04.012 · Cited by 34
The Relevance of Dual Diagnoses among Drug-Dependent Patients with Sleep Disorders
Roncero, C., García-Ullán, L., Bullón, A., Remón-Gallo, D., Vicente-Hernández, B., Alvarez, A. I., Caldero, A., Flores, A., & Aguilar, L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092862 · Cited by 33
Insomnia in Patients with Depression
Jindal, R. D. (2009) · CNS Drugs · doi:10.2165/00023210-200923040-00004 · Cited by 33
A double dissociation of memory impairments in major depression
Dresler, M., Kluge, M., Zeising, M., SCHÜSSLER, P., Steiger, A., & Genzel, L. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.07.015 · Cited by 33
Self-citationPharmacologic Treatment of Primary Insomnia
Hall-Porter, J. M., Curry, D. T., & Walsh, J. K. (2010) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2010.08.006 · Cited by 31
Koncz, S., Papp, N., Pothorszki, D., & Bagdy, G. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad050 · Cited by 30
Schilling, C., Gilles, M., Blum, W. F., Daseking, E., Colla, M., Weber-Hamann, B., Lederbogen, F., Krumm, B., Heuser, I., Wudy, S. A., et al. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31827cb179 · Cited by 30
Ambrogio, A. G., Giraldi, F. P., & Cavagnini, F. (2008) · Pituitary · doi:10.1007/s11102-008-0114-6 · Cited by 30
Dolev, Z. (2011) · Archives of Women s Mental Health · doi:10.1007/s00737-011-0205-7 · Cited by 29
Ghrelin effects expression of several genes associated with depression-like behavior
Poretti, M. B., Rask‐Andersen, M., Kumar, P., de Barioglio, S. R., de Cúneo, M. F., Schiöth, H. B., & Carlini, V. P. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.09.012 · Cited by 29
Fornaro, M., Caiazza, C., Simone, G. D., Rossano, F., & de Bartolomeis, A. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.11.033 · Cited by 28
Sleep Neurophysiology in Depression
Rosenblum, Y., Nakagawa, J., van Hattem, T., Krugliakova, E., Sabhapondit, B., Bovy, L., Mikoteit, T., Steiger, A., Zeising, M., & Dresler, M. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.07.023 · Cited by 28
Self-citationSleep electroencephalography as a biomarker in depression
Steiger, A., Pawlowski, M. A., & Kimura, M. (2015) · ChronoPhysiology and Therapy · doi:10.2147/cpt.s41760 · Cited by 27
Self-citationAuthier, S., Bassett, L., Pouliot, M., Rachalski, A., Troncy, É., Paquette, D., & Mongrain, V. (2014) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2014.05.003 · Cited by 26
Yeephu, S., Suthisisang, C. C., Suttiruksa, S., Prateepavanich, P., Limampai, P., & Russell, I. J. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r725 · Cited by 26
Scharnholz, B., Weber-Hamann, B., Lederbogen, F., Schilling, C., Gilles, M., Onken, V., Frankhauser, P., Kopf, D., & Deuschle, M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.08.010 · Cited by 26
Manosso, L. M., Duarte, L. A., Martinello, N. S., de Mathia, G. B., & Réus, G. Z. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273254093231020052002 · Cited by 25
Al‐Majed, A. A., Bakheit, A. H. H., Alharbi, R. M., & Abdel‐Aziz, H. A. (2018) · Profiles of drug substances, excipients, and related methodology · doi:10.1016/bs.podrm.2018.01.002 · Cited by 25
Ricken, R., Bopp, S., Schlattmann, P., Himmerich, H., Bschor, T., Richter, C., Elstner, S., Stamm, T. J., Schulz-Ratei, B., Lingesleben, A., et al. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw082 · Cited by 24
Li, M., Cui, J., Xu, B., Wei, Y., Fu, C., Lv, X., Xiong, L., & Qin, D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.827541 · Cited by 23
Neural Correlates of Perceived Confidence in a Partial Report Paradigm
Graziano, M., Parra, L. C., & Sigman, M. (2014) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00759 · Cited by 23
Özsoy, S., Beşirli, A., Ünal, D., Abdülrezzak, Ü., & Orhan, O. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.09.002 · Cited by 23
Adamczyk, M., Gazea, M., Wollweber, B., Holsboer, F., Dresler, M., Steiger, A., & Pawlowski, M. A. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.007 · Cited by 22
Self-citationEffects of Amitriptyline and Escitalopram on Sleep and Mood in Patients With Functional Dyspepsia
Herrick, L. M., Camilleri, M., Schleck, C. D., Zinsmeister, A. R., Saito, Y. A., & Talley, N. J. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.10.021 · Cited by 22
Dreams, Sleep, and Psychotropic Drugs
Nicolas, A., & Ruby, P. M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.507495 · Cited by 21
Sleep and physiological systems: a functional perspective
Manzar, M. D., Zannat, W., & Hussain, M. E. (2014) · Biological Rhythm Research · doi:10.1080/09291016.2014.966504 · Cited by 20
Markers of mineralocorticoid receptor function
Murck, H., Braunisch, M. C., Konrad, C., Ježová, D., & Kircher, T. T. J. (2018) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000239 · Cited by 20
Fighting Insomnia and Battling Lethargy: The Yin and Yang of Palliative Care
Davis, M. P., & Goforth, H. W. (2014) · Current Oncology Reports · doi:10.1007/s11912-014-0377-1 · Cited by 18
Leptin concentration indexed to fat mass is increased in untreated anorexia nervosa (AN) patients
Üzüm, A. K., Yücel, B., Ömer, B., İşsever, H., & Özbey, N. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03423.x · Cited by 18
Wichniak, A., Wierzbicka, A., & Jernajczyk, W. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.06.010 · Cited by 16
Self-citationIto, H., Tsuneki, H., Sasaoka, T., Toyooka, N., Matsuo, M., & Yamazaki, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264386 · Cited by 15
Ghrelin mediated regulation of neurosynaptic transmitters in depressive disorders
Masule, M. V., Rathod, S., Agrawal, Y. O., Patil, C. R., Nakhate, K. T., Ojha, S. K., Goyal, S. N., & Mahajan, U. B. (2022) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100113 · Cited by 15
Dekeyne, A., & Millan, M. J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1259-8 · Cited by 15
A Phase 2 Randomized Dose-Finding Study With Esmirtazapine in Patients With Primary Insomnia
Ruwe, F., IJzerman‐Boon, P. C., Roth, T. G., Zammit, G. K., & Ivgy-May, N. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000546 · Cited by 14
Metadata
- Authors
- Schmid, D. A., Wichniak, A., Uhr, M., Ising, M., Brunner, H., Held, K., Weikel, J. C., Sonntag, A., & Steiger, A.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Max Planck Society (DE)
- Corresponding author
- Steiger, Axel
- Venue
- Neuropsychopharmacology
- Published
- 2005-10-19
- Volume
- 31
- Issue
- 4
- Pages
- 832-844
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1985871443
- Cited by
- 165
- References
- 90
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 4 · 2023: 12 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 7 · 2017: 9 · 2016: 2 · 2015: 9 · 2014: 13 · 2013: 9 · 2012: 14
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- mirtazapine, depression, sleep architecture, sleep EEG, hypothalamic-pituitary-adrenal axis, cortisol, ACTH, growth hormone, prolactin, melatonin, ghrelin, leptin, 5-HT2 receptor, antidepressant side effects
- MeSH terms
- Mirtazapine, Adrenocorticotropic Hormone, Adult, Animals, Antidepressive Agents, Tricyclic, Body Weight, Circadian Rhythm, Depression, Dexamethasone, Dose-Response Relationship, Drug, Electroencephalography, Endocrine System, Female, Hormones, Humans, Hydrocortisone, Male, Melatonin, Mianserin, Middle Aged, Prolactin, Psychometrics, Sleep, Growth Hormone, Time Factors, Immunoradiometric Assay, Area Under Curve, Leptin, Peptide Hormones, Ghrelin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review